Previous OM in the News posts have looked at the IV bag shortage in the medical supply chain, and many other shortages of medications and supplies. The causes of the shortages are many, including quality issues at production facilities, and Hurricane Maria’s damage to production facilities on Puerto Rico.
Shortages in this particular supply chain can have deadly consequences, and the risks need to be addressed.
Over the years, the supply chain for medical products and medicines has become very lean, and many items are manufactured off-shore. The last penicillin production in the US was in 2004. Only 10% of the generic drugs used in the U.S. are made onshore, and eighty percent of the active ingredients in medications are produced overseas, mainly India and China.
Considering the length of the supply chain, combined with ongoing shortages, does a lean medical supply chain present a threat to national security?
This post is based on the Wired article, Medicine’s Long, Thin Supply Chain, by Maryn McKenna, March 5, 2018. Image source: Douglas Sacha/Getty Images.
1. Should the United States Government develop policies to insure that critical medial products and medicine are produced Continue reading